Oseltamivir
Sold as Cipla-oseltamivir, Tamiflu, Aviflu, Oseltamivir adco, Anviatir, Oseltamivir zydus, Oselow, Osetamza, Flumitev, Oseltrex
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
Drag to rotate. Structure from PubChem CID 65028.
Background
Registration
- Applicants
- 7
- Registrations
- 27
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) LtdCertificate held by Cipla Medpro (Pty) Ltd. | Cipla-oseltamivir | 75 mg | 410799 | S4 | PIPIL |
| Roche Products (Pty) Ltd | Tamiflu | 6 mg/ml, 30 mg, 45 mg, 75 mg | 421020, 421021, 471194, A400578 | S4 | None |
| Adcock ingram limited | Aviflu, Oseltamivir adco | 30 mg, 45 mg, 75 mg | 450164, 540687, 540688, 540689, 550359, 550360 | S4 | None |
| Zydus Healthcare (Pty) LtdCertificate held by Zydus Healthcare SA (Pty) Ltd | Anviatir, Oseltamivir zydus | 30, 45, 75 | 550686, 550687, 550688, 550689.686, 550690.687, 550691.688 | S4 | PIPIL |
| Lebasi Pharmaceuticals (Pty) Ltd | Oselow, Osetamza | 30, 45, 75 | 560270, 560271, 560272, 560273.270, 560274.271, 560275.272 | S4 | None |
| Teva Pharmaceuticals (Pty) Ltd | Flumitev | 30, 45, 75 | 561035, 561036, 561037 | S4 | PIPIL |
| Activo Health (Pty) Ltd | Oseltrex | 75 mg | 570502 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla-oseltamivir EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 mgCapsules. | 41079941/20.2.8/0799Approved 20 May 2023 | Registered | S4 | PIPIL |
| Tamiflu 30 MG EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30 mg | 42102042/20.2.8/1020 | Registered | S4 | None |
| Tamiflu 45 MG EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45 mg | 42102142/20.2.8/1021 | Registered | S4 | None |
| Aviflu 75 MG EACH CAPSULE CONTAINS: OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 mg | 45016445/20.2.8/0164 | Registered | S4 | None |
| Tamiflu 6 mg/ml EACH 1,0 ml SUSPENSION CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 6,0 mg | 6 mg/ml | 47119447/20.2.8/1194 | Registered | S4 | None |
| Oseltamivir adco 30 MG EACH CAPSULE CONTAINS: OSELTAMIVIR PHOSPHATE 30,0 mg | 30 mg | 54068754/20.2.8/0687 | Registered | S4 | None |
| Oseltamivir adco 45 MG EACH CAPSULE CONTAINS: OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45 mg | 54068854/20.2.8/0688 | Registered | S4 | None |
| Oseltamivir adco 75 MG EACH CAPSULE CONTAINS: OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 mg | 54068954/20.2.8/0689 | Registered | S4 | None |
| Aviflu 30 MG EACH CAPSULE CONTAINS: OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30 mg | 55035955/20.2.8/0359 | Registered | S4 | None |
| Aviflu 45 MG EACH CAPSULE CONTAINS: OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45 mg | 55036055/20.2.8/0360 | Registered | S4 | None |
| Anviatir 30 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30Hard capsule | 55068655/20.2.8/0686Approved 26 April 2024 | Registered | S4 | PIPIL |
| Anviatir 45 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45Hard capsule | 55068755/20.2.8/0687Approved 26 April 2024 | Old Medicine | S4 | PIPIL |
| Anviatir 75 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75Hard capsule | 55068855/20.2.8/0688Approved 26 April 2024 | Old Medicine | S4 | PIPIL |
| Oseltamivir 30 zydus EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30Hard capsule | 550689.68655/20.2.8/0689.686Approved 26 April 2024 | Old Medicine | S4 | PIPIL |
| Oseltamivir 45 zydus EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45Hard capsule | 550690.68755/20.2.8/0690.687Approved 26 April 2024 | Old Medicine | S4 | PIPIL |
| Oseltamivir 75 zydus EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75Hard capsule | 550691.68855/20.2.8/0691.688Approved 26 April 2024 | Old Medicine | S4 | PIPIL |
| Oselow 30 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30 | 56027056/20.2.8/0270 | Registered | S4 | None |
| Oselow 45 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45 | 56027156/20.2.8/0271 | Registered | S4 | None |
| Oselow 75 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 | 56027256/20.2.8/0272 | Registered | S4 | None |
| Osetamza 30 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30 | 560273.27056/20.2.8/0273.270 | Registered | S4 | None |
| Osetamza 45 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 45,0 mg | 45 | 560274.27156/20.2.8/0274.271 | Registered | S4 | None |
| Osetamza 75 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 | 560275.27256/20.2.8/02750272 | Registered | S4 | None |
| Flumitev 30 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg | 30Capsule | 56103556/20.2.8/1035Approved 10 September 2024 | Registered | S4 | PIPIL |
| Flumitev 45 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 45Capsule | 56103656/20.2.8/1036Approved 10 September 2024 | Registered | S4 | PIPIL |
| Flumitev 75 EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75Capsule | 56103756/20.2.8/1037Approved 10 September 2024 | Registered | S4 | PIPIL |
| Oseltrex EACH TABLET CONTAINS: OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 mgTablets | 57050257/20.2.8/0502Approved 20 January 2026 | Registered | S4 | PIPIL |
| Tamiflu 75 MG EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg | 75 mg | A400578A40/20.2.8/0578 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Oseltamivir phosphate equivalent to oseltamivir
S4: Oseltamivir
Consolidated Schedules 06 July 2026, line 7416
Pharmacological class: Antiviral agents. (class 20.2.8)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.